Capstone (NASDAQ: CAPS)
$1.76
(0.0%)
$0.00
Price as of June 23, 2025, 2:39 p.m. ET
Capstone Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Capstone Company Info
Capstone Therapeutics Corp. is a biotechnology company. It develops a pipeline of novel therapeutic peptides and other molecules aimed at helping patients with under-served medical conditions. The company was founded in July 1987 and is headquartered in Alsip, IL.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.